Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014)

Bio-Techne's (TECH) quarterly Amortization - Intangibles came in at $5.7 million in Q3 2014, up 161.79% year-on-year from $2.2 million in Q3 2013, and up 161.79% quarter-over-quarter from $2.2 million in Q3 2013.

Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014) Analysis & Trends

Bio-Techne's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $5.7 million for Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Sep 30, 2014 5.73 Mn
Sep 30, 2013 2.19 Mn
Mar 31, 2011 170,000.00
Dec 31, 2010 171,000.00
Sep 30, 2010 170,000.00
Mar 31, 2010 240,000.00
Dec 31, 2009 240,000.00
Sep 30, 2009 240,000.00